Using objective markers to assess participant behavior in HIV prevention trials of vaginal microbicides

Journal of Acquired Immune Deficiency Syndromes

Volumn 49, Issue 1, 2008, Pages 64-69

  Mauck, Christine K ^a   Straten, Ariane Van Der ^b,c  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c RTI INTERNATIONAL   (United States)

Author keywords

Adherence; Behavior; Biomarkers; Clinical trials; Condoms; Microbicides

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CARBOPOL 974P; CARRAGEENAN; MICROBICIDE; N [4 CHLORO 3 (3 METHYL 2 BUTENYLOXY)PHENYL] 2 METHYL 3 FURANCARBOTHIOAMIDE; TENOFOVIR; VIVAGEL; ANTIINFECTIVE AGENT; BIOLOGICAL MARKER;

BEHAVIORAL RESEARCH; CLINICAL TRIAL; CONDOM; DRUG ABSORPTION; DRUG METABOLISM; DRUG RESEARCH; DRUG TISSUE LEVEL; EXPOSURE; FEMALE; FUNDING; HEALTH CARE UTILIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; INFECTION PREVENTION; INFECTION RISK; PATIENT COMPLIANCE; PATIENT PARTICIPATION; PRIORITY JOURNAL; REVIEW; RISK MANAGEMENT; RISK REDUCTION; SELF REPORT; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SINGLE DRUG DOSE; SPERM; UTERINE CERVICITIS; VAGINITIS; VIRUS TRANSMISSION; ARTICLE; PSYCHOLOGICAL ASPECT; RISK; UNSAFE SEX;

ANTI-INFECTIVE AGENTS; BIOLOGICAL MARKERS; CLINICAL TRIALS AS TOPIC; CONDOMS; FEMALE; HIV INFECTIONS; HUMANS; RISK; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; UNSAFE SEX;

EID: 52049098324     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318183a917     Document Type: Review

References (19)

1. MDS Working Groups. The Microbicide Development Strategy. Silver Spring, MD: Alliance for Microbicide Development; 2006.
2. Boyce L, Plescia C, Finley B, et al. The microbicide field response to clinical trial challenges. Poster presented at: International AIDS Society meeting, Sydney, Australia, 2007. Available at: http://www.ias2007.org/pag/ Abstracts.aspx?AID=5159. Accessed May 16, 2008.
3. Padian NS, van der Straten A, Ramjee G, et al. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: A randomized controlled trial. Lancet. 2007. July 21, 2007;370:251-261.
4. Mensch B, Hewett P, Gregory R. Sexual Behavior and STI/HIV Status Among Adolescents in Rural Malawi: An Evaluation of the Effect of Interview Mode on Reporting. Los Angeles, CA: Population Association of America Annual Meeting; 2006.
5. Minnis AM, Muchini A, Shiboski S, et al. Audio computer-assisted self-interviewing in reproductive health research: reliability assessment among women in Harare, Zimbabwe. Contraception. 2007;75:59-65.
6. Turner C, Ku L, Rogers S. Adolescent sexual behavior, drug use, and violence: increased reporting with computer survey technology. Science. 1998;280:867-873.
7. Clark J, Tifft L. Polygraph and interview validation on self-reported deviant behavior. Am Sociol Rev. 1966;31:516-523.
8. Catania JA, Binson D, van der Straten A, et al. Methodological research on sexual behavior in the AIDS era. In: Rosen RC, Davis CM, Ruppel HJ Jr, eds. Annual Review of Sex Research: An Integrative and Interdisciplinary Review. A Publication of the Society for the Scientific Study of Sexuality; 1995;VI:77-125.
9. Mauck CK, Doncel GF; Biomarkers of Semen Exposure Clinical Working Group. Biomarkers of semen in the vagina: applications in clinical trials of contraception and prevention of sexually transmitted pathogens including HIV. Contraception. 2007;75:407-419. Epub April 30, 2007.
10. Macaluso M, Lawson L, Akers R, et al. Prostate-specific antigen in vaginal fluid as a biologic biomarker of condom failure. Contraception. 1999;59:195-201.
11. Pang BCM, Cheung BKK. Identification of human semenogelin in membrane strip test as an alternative method for the detection of semen. Forensic Sci Int. 2006, doi:10.1016/j.forsciint.2006.07.021.
12. Wallace A, Thorn M, Maguire RA, et al. Assay for establishing whether microbicide applicators have been exposed to the vagina. Sex Transm Dis. 2004;31:465-468.
13. Wallace AR, Teitelbaum A, Wan L, et al. Determining the feasibility of utilizing the microbicide applicator compliance assay for use in clinical trials. Contraception. 2007;76:53-56.
14. Ibis Reproductive Health Organization Report 2002-2005, Page 6. Available at: http://www.ibisreproductivehealth.org/projects/hivprevention/ smartdiaphragm.cfrn. Accessed May 16, 2008.
15. Wawer MJ, Gray RH, Sewankambo NK, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis. 2005;191:1403-1409. Epub March 30, 2005.
16. Lawson ML, Macaluso M, Bloom A, et al. Objective biomarkers of condom failure. Sex Transm Dis. 1998;25:427-432.
17. Macaluso M, Lawson L, Akers R, et al. Prostate-specific antigen in vaginal fluid as a biologic biomarker of condom failure. Contraception. 1999;59:195-201.
18. Tourangeau R, Smith TW, Rasinski KA. Motivation to report sensitive behaviors on surveys: evidence from a bogus pipeline experiment. JAppl Soc Psychol. 1997;27:209-222.
19. Gallo MF, Behets FM, Steiner MJ, et al. Validity of self-reported 'safe sex' among female sex workers in Mombasa, Kenya-PSA analysis. Int J STD AIDS. 2007;18:33-38.